Phospho-specific flow cytometry in drug discovery

Drug Discovery Today: Technologies

Volumn 2, Issue 3, 2005, Pages 295-302

  Clutter, Matthew R ^a   Krutzik, Peter O ^a   Nolan, Garry P ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB; GEFITINIB; IMATINIB; PROTEIN KINASE;

BAYES THEOREM; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER; CELL SELECTION; CORRELATION ANALYSIS; DISEASE MODEL; DRUG DETERMINATION; DRUG RESEARCH; DRUG SCREENING; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE SEQUENCE; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MOLECULAR LIBRARY; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; VALIDATION PROCESS; WESTERN BLOTTING;

EID: 27244444358     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2005.08.012     Document Type: Review

References (28)

1. P.O. Krutzik et al. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: Techniques and clinical applications Clin. Immunol. 110 2004 206-221
2. O.D. Perez and G.P. Nolan Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry Nat. Biotechnol. 20 2002 155-162
3. P.O. Krutzik et al. Characterization of the murine immunological signaling network with phosphospecific flow cytometry J. Immunol. 175 2005 2366-2373
4. P.O. Krutzik et al. Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry J. Immunol. 175 2005 2357-2365
5. G. Manning et al. The protein kinase complement of the human genome Science 298 2002 1912-1934
6. P. Cohen Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1 2002 309-315
7. J. Bain et al. The specificities of protein kinase inhibitors: An update Biochem. J. 371 Pt 1 2003 199-204
8. M.R. Green Targeting targeted therapy N. Engl. J. Med. 350 2004 2191-2193
9. S. Broder and J.C. Venter Sequencing the entire genomes of free-living organisms: The foundation of pharmacology in the new millennium Annu. Rev. Pharmacol. Toxicol. 40 2000 97-132
10. A.L. Hopkins and C.R. Groom The druggable genome Nat. Rev. Drug Discov. 1 2002 727-730
11. J. Drews Biotechnology's metamorphosis into a drug discovery industry Nat. Biotechnol. 16 Suppl. 1998 22-24
12. J. Drews Strategic trends in the drug industry Drug Discov. Today 8 2003 411-420
13. J.M. Reichert Trends in development and approval times for new therapeutics in the United States Nat. Rev. Drug Discov. 2 2003 695-702
14. J.A. DiMasi et al. The price of innovation: New estimates of drug development costs J. Health Econ. 22 2003 151-185
15. A. Kamb What's wrong with our cancer models? Nat. Rev. Drug Discov. 4 2005 161-165
16. D.F. Horrobin Modern biomedical research: An internally self-consistent universe with little contact with medical reality? Nat. Rev. Drug Discov. 2 2003 151-154
17. B.P. Zambrowicz and A.T. Sands Knockouts model the 100 best-selling drugs - will they model the next 100? Nat. Rev. Drug Discov. 2 2003 38-51
18. H. Kubinyi Drug research: Myths, hype and reality Nat. Rev. Drug Discov. 2 2003 665-668
19. E.C. Butcher Innovation: Can cell systems biology rescue drug discovery? Nat. Rev. Drug Discov. 4 2005 461-467
20. J.G. Lombardino and J.A. Lowe III The role of the medicinal chemist in drug discovery - then and now Nat. Rev. Drug Discov. 3 2004 853-862
21. W.P. Walters and M. Namchuk Designing screens: How to make your hits a hit Nat. Rev. Drug Discov. 2 2003 259-266
22. S.V. Russello Assessing cellular protein phosphorylation: High throughput drug discovery technologies Assay Drug Dev. Technol. 2 2004 225-235
23. K.A. Giuliano et al. Advances in high content screening for drug discovery Assay Drug Dev. Technol. 1 2003 565-577
24. O.D. Perez et al. Flow cytometric analysis of kinase signaling cascades Methods Mol. Biol. 263 2004 67-94
25. P.O. Krutzik and G.P. Nolan Intracellular phospho-protein staining techniques for flow cytometry: Monitoring single cell signaling events Cytometry A 55 2003 61-70
26. De Rosa, S.C. and Roederer, M. (2001) Eleven-color flow cytometry. A powerful tool for elucidation of the complex immune system. Clin. Lab. Med. 21, 697-712, vii
27. K. Sachs et al. Causal protein-signaling networks derived from multiparameter single-cell data Science 308 2005 523-529
28. J.M. Irish et al. Single cell profiling of potentiated phospho-protein networks in cancer cells Cell 118 2004 217-228